Arkansas Legal Resource Navigator

42 U.S.C. § 285c–2 — Division Directors for Diabetes, Endocrinology, and Metabolic Diseases, Digestive Diseases and Nutrition, and Kidney, Urologic, and Hematologic Diseases; functions

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 285c–2 — Division Directors for Diabetes, Endocrinology, and Metabolic Diseases, Digestive Diseases and Nutrition, and Kidney, Urologic, and Hematologic Diseases; functions

**(a)** (1) In the Institute there shall be a Division Director for Diabetes, Endocrinology, and Metabolic Diseases, a Division Director for Digestive Diseases and Nutrition, and a Division Director for Kidney, Urologic, and Hematologic Diseases. Such Division Directors, under the supervision of the Director of the Institute, shall be responsible for— (A) developing a coordinated plan (including recommendations for expenditures) for each of the national research institutes within the National Institutes of Health with respect to research and training concerning diabetes, endocrine and metabolic diseases, digestive diseases and nutrition, and kidney, urologic, and hematologic diseases; (B) assessing the adequacy of management approaches for the activities within such institutes concerning such diseases and nutrition and developing improved approaches if needed; (C) monitoring and reviewing expenditures by such institutes concerning such diseases and nutrition; and (D) identifying research opportunities concerning such diseases and nutrition and recommending ways to utilize such opportunities. (2) The Director of the Institute shall transmit to the Director of NIH the plans, recommendations, and reviews of the Division Directors under subparagraphs (A) through (D) of paragraph (1) together with such comments and recommendations as the Director of the Institute determines appropriate. **(b)** The Director of the Institute, acting through the Division Director for Diabetes, Endocrinology, and Metabolic Diseases, the Division Director for Digestive Diseases and Nutrition, and the Division Director for Kidney, Urologic, and Hematologic Diseases, shall— (1) carry out programs of support for research and training (other than training for which Ruth L. Kirschstei

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 285c–2

Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: 8aa84bbaff029fb26bb0de4c4b057e8e681505485ced1e466b9b60bb7dcbee08. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Record provenance

Stable record: federal_law:legal_authorities:record_usc_f2ea6873697903ba90227006
Source file: Laws/federal/codes/united-states-code/title-42/section-285c2-division-directors-for-diabetes-endocrinology-and-metabolic-diseases-dig--4f8e654124.md
Pages: Not recorded – Not recorded
Passage SHA-256: 1f104f540ffce33994d44fd72c8a5bb641240d5840e6a6b20fc414dd4e1a730a

Source location: Title 42, Chapter 6A, § 285c–2; chapter-6a-public-health-service.md

Stored source content

**(a)** (1) In the Institute there shall be a Division Director for Diabetes, Endocrinology, and Metabolic Diseases, a Division Director for Digestive Diseases and Nutrition, and a Division Director for Kidney, Urologic, and Hematologic Diseases. Such Division Directors, under the supervision of the Director of the Institute, shall be responsible for— (A) developing a coordinated plan (including recommendations for expenditures) for each of the national research institutes within the National Institutes of Health with respect to research and training concerning diabetes, endocrine and metabolic diseases, digestive diseases and nutrition, and kidney, urologic, and hematologic diseases; (B) assessing the adequacy of management approaches for the activities within such institutes concerning such diseases and nutrition and developing improved approaches if needed; (C) monitoring and reviewing expenditures by such institutes concerning such diseases and nutrition; and (D) identifying research opportunities concerning such diseases and nutrition and recommending ways to utilize such opportunities. (2) The Director of the Institute shall transmit to the Director of NIH the plans, recommendations, and reviews of the Division Directors under subparagraphs (A) through (D) of paragraph (1) together with such comments and recommendations as the Director of the Institute determines appropriate. **(b)** The Director of the Institute, acting through the Division Director for Diabetes, Endocrinology, and Metabolic Diseases, the Division Director for Digestive Diseases and Nutrition, and the Division Director for Kidney, Urologic, and Hematologic Diseases, shall— (1) carry out programs of support for research and training (other than training for which Ruth L. Kirschstein National Research Service Awards may be made under [section 288 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section288&num=0&edition=prelim)) in the diagnosis, prevention, and treatment of diabetes mellitus and endocrine and metabolic diseases, digestive diseases and nutritional disorders, and kidney, urologic, and hematologic diseases, including support for training in medical schools, graduate clinical training, graduate training in epidemiology, epidemiology studies, clinical trials, and interdisciplinary research programs; and (2) establish programs of evaluation, planning, and dissemination of knowledge related to such research and training.

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 288 — Ruth L. Kirschstein National Research Service Awards

**(a) Biomedical and behavioral research and research training; programs and institutions included; restriction; special consideration** (1) The Secretary shall— (A) provide Ruth L. Kirschstein National Research Service Awards for— (i) biomedical and behavioral research at the National Institutes of Health in matters relating to the cause, diagnosis, prevention, and treatment of the diseases or other health problems to which the activities of the National Institutes of Health and Administration 11 So in original. Reference to Administration probably should not appear. are directed; (ii) training at the National Institutes of Health and at the Administration 1 of individuals to undertake such research; (iii) biomedical and behavioral research and health services research (including research in primary medical care) at public and nonprofit private entities; and (iv) pre-doctoral and post-doctoral training at public and private institutions of individuals to undertake biomedical and behavioral research; (B) make grants to public and nonprofit private institutions to enable such institutions to make Ruth L. Kirschstein National Research Service Awards for research (and training to undertake biomedical and behavioral research) in the matters described in subparagraph (A)(i) to individuals selected by such institutions; and (C) provide contracts for scholarships and loan repayments in accordance with sections 288–4 and 288–5 22 See References in Text note below. of this title, subject to providing not more than an aggregate 50 such contracts during the fiscal years 1994 through 1996. A reference in this subsection to the National Institutes of Health shall be considered to include the institutes, agencies, divisions, and bureaus included in the

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 288

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.